• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Girls More Likely to Have Recurrent Depression

Girls More Likely to Have Recurrent Depression

March 1, 2011
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Editor-in-Chief, Caroline Fisher, PhD, MD. 

Subject:
DEPRESSION

Short Description:
Girls More Likely to Have Recurrent Depression

Background:
The Treatment for Adolescents With Depression Study (TADS) taught us that fluoxetine (Prozac) plus cognitive behavioral therapy was superior to medication alone or placebo for short-term recovery from major depressive disorder (MDD). But TADS didn’t tell us anything about long-term recovery. Researchers recently conducted a naturalistic follow-up study of participants in TADS to determine the incidence of long-term recovery from MDD, and predictive factors for recurrence. For this study, 196 participants in TADS were followed for up to five years after the start of that study to monitor recovery and recurrence of MDD. Recovery was defined as the absence of clinically significant symptoms of depression for eight weeks or longer, and recurrence was defined as a new episode of depression after a period of recovery. Almost all of the adolescents who were followed recovered from depression (96.4%) at some point. Of those who recovered, 91.5% did so by two years after enrollment in the trial. Recovery was not associated with having been in the most efficacious treatment group (Prozac plus CBT) in TADS, but rather was most strongly associated with having been a responder to short-term (12 week) treatment (as opposed to being a partial responder or a nonresponder, regardless of which treatment the participant responded to). However, by the end of the five-year follow-up period, 46.6% of participants had a recurrence. The other 53.4% stayed well through the end of the follow-up period. The mean time from recovery to recurrence was 22.3 months. Sex was the strongest predictor of recurrence, with 57% of females experiencing recurrence of MDD vs 32.9% of males (Curry J et al, Arch Gen Psychiatry Nov 1, 2010:online ahead of print).

TCPR's Take:
The good news is that most of the adolescents recovered; however, as seen elsewhere, earlier onset of symptoms predict a worse lifetime course: in this case, more frequent recurrence than later onset (adult) depression. This study also reminds us that there are gender differences in depression. Adolescent females are more likely to become depressed, and this study shows that they are also significantly more likely to experience more than one episode of depression.

Child Psychiatry
KEYWORDS child-psychiatry depressive_disorder women's_issues_in_psychiatry
    www.thecarlatreport.com
    Issue Date: March 1, 2011
    SUBSCRIBE NOW
    Table Of Contents
    The Pharmacological Treatment of Sleep Disorders in Children: An Overview
    Insomnia and Mood Disorders in Adolescents
    Normal and Disordered Sleep in Kids
    Normal Sleep Requirements for Healthy Kids
    Girls More Likely to Have Recurrent Depression
    Single Therapy Session Works to Reduce Violence and Alcohol Misuse
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.